Baird Financial Group Inc. Purchases 50,328 Shares of Haleon PLC Sponsored ADR $HLN

Baird Financial Group Inc. lifted its position in Haleon PLC Sponsored ADR (NYSE:HLN) by 264.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,350 shares of the company’s stock after acquiring an additional 50,328 shares during the quarter. Baird Financial Group Inc.’s holdings in Haleon were worth $714,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in Haleon during the 4th quarter valued at about $187,000. Ameriprise Financial Inc. lifted its holdings in Haleon by 15.8% during the 4th quarter. Ameriprise Financial Inc. now owns 120,122 shares of the company’s stock valued at $1,146,000 after buying an additional 16,429 shares in the last quarter. Balyasny Asset Management L.P. bought a new stake in Haleon during the 4th quarter valued at about $2,555,000. Focus Partners Wealth lifted its holdings in Haleon by 132.0% during the 4th quarter. Focus Partners Wealth now owns 67,928 shares of the company’s stock valued at $686,000 after buying an additional 38,651 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in Haleon by 82.5% during the 4th quarter. Millennium Management LLC now owns 528,891 shares of the company’s stock valued at $5,046,000 after buying an additional 239,019 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Up 0.3%

Shares of Haleon stock opened at $9.77 on Wednesday. The firm’s 50 day moving average price is $9.76 and its 200-day moving average price is $10.21. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 52-week low of $8.86 and a 52-week high of $11.42. The company has a market cap of $43.76 billion, a P/E ratio of 25.05, a PEG ratio of 2.87 and a beta of 0.24.

Haleon Increases Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 18th. Stockholders of record on Friday, August 15th will be issued a $0.0555 dividend. This is an increase from Haleon’s previous semi-annual dividend of $0.05. The ex-dividend date of this dividend is Friday, August 15th. This represents a dividend yield of 190.0%. Haleon’s payout ratio is currently 28.21%.

Wall Street Analyst Weigh In

Several research firms have recently commented on HLN. Wall Street Zen lowered shares of Haleon from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. BNP Paribas upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, May 27th. Finally, BNP Paribas Exane upgraded shares of Haleon from a “neutral” rating to an “outperform” rating and set a $13.40 price target for the company in a report on Tuesday, May 27th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.